Detalles de la búsqueda
1.
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study.
Lancet Oncol
; 22(2): 212-222, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33460574
2.
Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance).
Support Care Cancer
; 24(6): 2661-7, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26768436
3.
Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance).
Cancer
; 120(22): 3575-83, 2014 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25043153
4.
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).
J Clin Oncol
; 42(12): 1344-1349, 2024 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38335467
5.
Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer.
Breast Cancer Res Treat
; 124(2): 433-9, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20309628
6.
Closing the Rural Cancer Care Gap: Three Institutional Approaches.
JCO Oncol Pract
; 16(7): 422-430, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32574128
7.
Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance).
J Clin Pharmacol
; 60(4): 444-452, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31802506
8.
Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance).
J Clin Oncol
; 38(12): 1284-1292, 2020 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32125937
9.
Pemetrexed, Bevacizumab, or the Combination As Maintenance Therapy for Advanced Nonsquamous Non-Small-Cell Lung Cancer: ECOG-ACRIN 5508.
J Clin Oncol
; 37(26): 2360-2367, 2019 09 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31361535
10.
Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study.
Clin Breast Cancer
; 19(4): 225-235.e2, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30928413
11.
Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel.
Cancer Treat Rev
; 34(3): 223-30, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18234424
12.
Capacity for Cancer Care Delivery Research in National Cancer Institute Community Oncology Research Program Community Practices: Availability of Radiology and Primary Care Research Partners.
J Am Coll Radiol
; 14(12): 1530-1537, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29055605
13.
Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance).
AAPS J
; 19(5): 1411-1423, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28620884
14.
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology).
J Clin Oncol
; 35(23): 2647-2655, 2017 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28398846
15.
Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol INT-0102.
J Clin Oncol
; 23(33): 8313-21, 2005 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16293862
16.
Assessing Clinical Trial-Associated Workload in Community-Based Research Programs Using the ASCO Clinical Trial Workload Assessment Tool.
J Oncol Pract
; 12(5): e536-47, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27006354
17.
Induction paclitaxel/carboplatin followed by concurrent chemoradiation therapy for unresectable stage III non-small-cell lung cancer: a limited-access study--CALGB 9534.
Clin Lung Cancer
; 7(1): 47-53, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16098244
18.
Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance).
J Clin Oncol
; 33(21): 2361-9, 2015 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26056183
19.
70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808.
Int J Radiat Oncol Biol Phys
; 59(2): 460-8, 2004 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15145163
20.
Neoadjuvant and adjuvant chemotherapy with doxorubicin and docetaxel in locally advanced breast cancer.
Clin Breast Cancer
; 5(5): 377-84, 2004 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-15585077